GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 3902X
GlaxoSmithKline PLC
18 December 2019
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr R Simard

b)

Position/status

President, Pharmaceuticals Supply Chain

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

 

b)

Nature of the transaction

Following the final vesting on 16 December 2019 of an award made on 13 December 2013 under the GlaxoSmithKline Deferred Investment Award programme, Mr Simard will receive a cash payment of £60,237.79 less applicable tax withholding in respect of 3,414.453 notional Ordinary Shares.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£17.642

3,414.453

 

 

 

 

 

d)

Aggregated information

 

 

N/A (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2019-12-16

f)

Place of the transaction

 

N/A

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHQVLFFKLFEFBZ